Zhang YuZhen, Da Silva Jaqueline R, Reilly Muredach, Billheimer Jeffrey T, Rothblat George H, Rader Daniel J
Institute for Translational Medicine and Therapeutics and Cardiovascular Institute, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.
J Clin Invest. 2005 Oct;115(10):2870-4. doi: 10.1172/JCI25327.
Hepatic expression of the scavenger receptor class B type I (SR-BI) promotes selective uptake of HDL cholesterol by the liver and is believed to play a role in the process of reverse cholesterol transport (RCT). We hypothesized that hepatic SR-BI expression is a regulator of the rate of integrated macrophage-to-feces RCT and used an in vivo model to test this hypothesis. Cholesterol-loaded and [3H]cholesterol-labeled J774 macrophages were injected intraperitoneally into mice, after which the appearance of the [3H]cholesterol in the plasma, liver, and feces over 48 hours was quantitated. Mice overexpressing SR-BI in the liver had significantly reduced [3H]cholesterol in the plasma but markedly increased [3H] tracer excretion in the feces over 48 hours. Conversely, mice deficient in SR-BI had significantly increased [3H]cholesterol in the plasma but markedly reduced [3H] tracer excretion in the feces over 48 hours. These studies demonstrate that hepatic SR-BI expression, despite its inverse effects on steady-state plasma HDL cholesterol concentrations, is an important positive regulator of the rate of macrophage RCT.
I型清道夫受体B类(SR-BI)的肝脏表达促进肝脏对高密度脂蛋白胆固醇的选择性摄取,并被认为在胆固醇逆向转运(RCT)过程中发挥作用。我们假设肝脏SR-BI表达是巨噬细胞到粪便的整体RCT速率的调节剂,并使用体内模型来验证这一假设。将负载胆固醇并经[3H]胆固醇标记的J774巨噬细胞腹腔注射到小鼠体内,然后定量测定48小时内血浆、肝脏和粪便中[3H]胆固醇的出现情况。肝脏中过表达SR-BI的小鼠在48小时内血浆中的[3H]胆固醇显著降低,但粪便中的[3H]示踪剂排泄明显增加。相反,SR-BI缺陷的小鼠在48小时内血浆中的[3H]胆固醇显著增加,但粪便中的[3H]示踪剂排泄明显减少。这些研究表明,肝脏SR-BI表达尽管对稳态血浆高密度脂蛋白胆固醇浓度有相反作用,但却是巨噬细胞RCT速率的重要正向调节剂。